19 followers
Evaluation of neurological changes in secondary progressive multiple sclerosis patients treated with immune modulator MIS416: results from a feasib... - PubMed - NCBI https://t.co/NTeQ51T596
Evaluation of neurological changes in secondary progressive multiple sclerosis patients treated with immune modulator MIS416: results from a feasib... - PubMed - NCBI https://t.co/NTeQ51T596
RT @MedicalEvidence: Study shows the feasibility of using patient-centered outcomes as additional clinical trial endpoints for determining…
Study shows the feasibility of using patient-centered outcomes as additional clinical trial endpoints for determining the efficacy of disease-modifying therapies: https://t.co/harD24ldOB